Drug
Alpha 1 Proteinase Inhibitor
Alpha 1 Proteinase Inhibitor: highest development phase Phase 2/3, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| alpha-1-Proteinase Inhibitor NCT01370018 | Phase 2/3 | HIV Disease |
Latest
No recent events.
Follow Alpha 1 Proteinase Inhibitor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.